MINAPHARM Pharmaceuticals (EGX:MIPH)

Egypt · Delayed Price · Currency is EGP

663.03

+2.37 (0.36%)

At close: Jun 24, 2026

199.99% (1Y)

Market Cap	7.81B +198.9%
Revenue (ttm)	6.44B +15.0%
Net Income	6.62M -74.4%
EPS	0.60 -94.8%
Shares Out	11.78M
PE Ratio	1,180.69
Forward PE	n/a
Dividend	2.50 (0.38%)
Ex-Dividend Date	Aug 13, 2025

Volume	2,336
Open	660.66
Previous Close	660.66
Day's Range	661.00 - 673.98
52-Week Range	214.70 - 772.00
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals produces medicines, chemicals, medical and dental supplies, cosmetics, veterinary and herbal medicines, and dietary supplements in Egypt and internationally. It operates through Biological Production, Drug Production, and Other Pharmaceuticals segments. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and h... [Read more]

Industry Pharmaceutical Preparations

Founded 1958

Employees 450

Stock Exchange Egyptian Stock Exchange

Ticker Symbol MIPH

Full Company Profile

Financial Performance

In 2025, MINAPHARM Pharmaceuticals's revenue was 6.44 billion, an increase of 14.97% compared to the previous year's 5.60 billion. Earnings were 6.62 million, a decrease of -94.84%.

Financial Statements